Longeveron Inc. (NASDAQ: LGVN)
$3.97
+0.4500 ( +12.78% ) 22.2M
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Data
Open
$3.97
Previous close
$3.52
Volume
22.2M
Market cap
$38.21M
Day range
$3.55 - $4.95
52 week range
$0.77 - $36.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 02, 2023 |
4 | Insider transactions | 1 | Aug 02, 2023 |
3 | Insider transactions | 2 | Aug 02, 2023 |
8-k | 8K-related | 14 | Jul 20, 2023 |
4 | Insider transactions | 1 | Jul 17, 2023 |
3 | Insider transactions | 2 | Jul 13, 2023 |
8-k | 8K-related | 12 | Jul 05, 2023 |